Functionalization of Platinum Complexes for Biomedical Applications.
about
Oxidative DNA double strand breaks and autophagy in the antitumor effect of sterically hindered platinum(II) complexes in NSCLCsRuthenium-conjugated chrysin analogues modulate platelet activity, thrombus formation and haemostasis with enhanced efficacyRuthenium Complexes Induce HepG2 Human Hepatocellular Carcinoma Cell Apoptosis and Inhibit Cell Migration and Invasion through Regulation of the Nrf2 PathwayTetraphenylethene-based highly emissive metallacage as a component of theranostic supramolecular nanoparticles.Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer.BODIPY-Appended 2-(2-Pyridyl)benzimidazole Platinum(II) Catecholates for Mitochondria-Targeted Photocytotoxicity.Platinum complexes as light promoted anticancer agents: a redefined strategy for controlled activation.Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs.Multifunctional platinum-based nanoparticles for biomedical applications.Protein Staining Agents from Cationic and Neutral Luminescent Iridium(III) Complexes.The Platin-X series: activation, targeting, and delivery.On the binding modes of metal NHC complexes with DNA secondary structures: implications for therapy and imaging.M2L4 coordination capsules with tunable anticancer activity upon guest encapsulation.Comprehensive Vibrational Spectroscopic Investigation of trans,trans,trans-[Pt(N3)2(OH)2(py)2], a Pt(IV) Diazido Anticancer Prodrug Candidate.Enhancing Therapeutic Efficacy of Cisplatin by Blocking DNA Damage Repair.Photoactive platinum(ii) β-diketonates as dual action anticancer agents.Half-sandwich ruthenium(ii) complexes containing N^N-chelated imino-pyridyl ligands that are selectively toxic to cancer cells.Supramolecular chemotherapy based on host-guest molecular recognition: a novel strategy in the battle against cancer with a bright future.Bioconjugation strategies to couple supramolecular exo-functionalized palladium cages to peptides for biomedical applications.Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents.An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.Functional insights into the cellular response triggered by a bile-acid platinum compound conjugated to biocompatible ferric nanoparticles using quantitative proteomic approaches.A macromolecular cyclometalated gold(iii) amphiphile displays long-lived emissive excited state in water: self-assembly and in vitro photo-toxicity.Discrete polygonal supramolecular architectures of isocytosine-based Pt(ii) complexes at the solution/graphite interface.Increased autophagy in EOC re-ascites cells can inhibit cell death and promote drug resistance.Protected and De-protected Platinum(IV) Glycoconjugates With GLUT1 and OCT2-Mediated Selective Cancer Targeting: Demonstrated Enhanced Transporter-Mediated Cytotoxic Properties andPt(IV)/Re(I) Chitosan Conjugates as a Flexible Platform for the Transport of Therapeutic and/or Diagnostic Anticancer Agents
P2860
Q33761590-282FC1BE-8438-491C-83DB-9D2F15AE8F21Q33915894-E477B863-997F-41A7-A465-67F7F97A00A2Q36939364-C55CBE71-3BA2-4C43-80A4-2989839DB249Q37473897-D359836C-DC11-4536-A9BA-77368F9E7A28Q38633157-0E65C246-A5B8-430A-8F1A-51C445718212Q38755315-36C9DD32-00F0-46A3-8733-4954872A9C54Q38791247-2C0807F3-E800-47C9-A660-B85755DF1CCDQ38791841-43E34739-FE04-4B81-BDBA-0AF9C6357111Q38812240-30B01345-284F-4DB0-82F7-BB204BFEAED5Q38818286-0D0006F8-8A8F-4C6C-A2AA-8735C6012274Q38919253-969B8415-1854-4A96-8E9A-05845264AB0CQ39399932-5CB51A4E-F845-44A0-A329-C31099C0DDA6Q39528351-91D90C78-BFD7-46CE-9E75-631E3D7C66FDQ39712535-A46B0D95-4F22-478B-B6E1-32E914BEED2EQ42108356-C592AC8F-7B75-46EC-9AE8-DD860FC400D7Q46506519-2B635C47-3CBC-468B-AA67-18EE367F5005Q47343997-07DC7EC1-DF9A-4DDC-9C20-79B354EB590BQ47599299-BDFA44B7-3587-478C-BCCC-7C8BB34592E7Q48359929-2EEA8814-F1B8-468B-8530-CF0B78A64198Q48361294-71654584-5EB8-4497-B132-EFC5E2A2983EQ50783492-D2730DF1-747D-435B-AEF1-ED40F25FA224Q50905468-36ED57F9-D8A8-4070-A881-E28F91045109Q52842895-8CC9FE6C-A9BE-447B-AAC7-B71B557FBDA9Q52954002-C5A5DBFA-5F47-4119-8F10-E97D525A88AFQ55118405-8AE52257-9645-4035-AD7B-491A3CDF4BFBQ57300005-74CDAB99-8395-4691-AE36-173684EF1762Q59229015-3B7B92D3-3650-47C4-A88E-EFE22A7BE939
P2860
Functionalization of Platinum Complexes for Biomedical Applications.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Functionalization of Platinum Complexes for Biomedical Applications.
@en
type
label
Functionalization of Platinum Complexes for Biomedical Applications.
@en
prefLabel
Functionalization of Platinum Complexes for Biomedical Applications.
@en
P2093
P1476
Functionalization of Platinum Complexes for Biomedical Applications.
@en
P2093
Xiaohui Wang
Xiaoyong Wang
Zijian Guo
P304
P356
10.1021/ACS.ACCOUNTS.5B00203
P407
P577
2015-08-06T00:00:00Z